Table 3. Comparison of our case to other recent reports of COVID Induced TTP.
Case | Our case | Albiol et al. [5] | Capecchi et al. [6] | Beaulieu et al. [7] |
Age (years) | 30 | 57 | 55 | 70 |
Time from COVID diagnosis to TTP diagnosis | Unclear but approximately 1 week | 6 days | 3 days | 19 days |
Platelets (k/mcl) – at time of diagnosis/at time of discharge | 9 / 374 | 22 /220 | 14 / 207 | 18 / normalized |
Lactate Dehydrogenase (U/L) – at time of diagnosis/at time of discharge | 1068 / 210 | 1451 / 218 | 18015 / 221 | Elevated / normalized |
Haptoglobin – at time of diagnosis/at time of discharge | <10 / 129 | - | <10 / 146 | < 10 / normalized |
ADAMTS13 Activity (%) – at time of diagnosis/at time of discharge | 3 / 54 | 2 / 89 | <3 / 59 | <10 / 43 |
ADAMTS13 Inhibitor (BU) – at time of diagnosis/at time of discharge | 0.6 / 0.0 | 5.2 / 2.5 | 31 / <12 | Weakly positive / < 0.5 |